1
|
Verma J, Warsame C, Seenivasagam RK, Katiyar NK, Aleem E, Goel S. Nanoparticle-mediated cancer cell therapy: basic science to clinical applications. Cancer Metastasis Rev 2023; 42:601-627. [PMID: 36826760 PMCID: PMC10584728 DOI: 10.1007/s10555-023-10086-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Accepted: 01/16/2023] [Indexed: 02/25/2023]
Abstract
Every sixth person in the world dies due to cancer, making it the second leading severe cause of death after cardiovascular diseases. According to WHO, cancer claimed nearly 10 million deaths in 2020. The most common types of cancers reported have been breast (lung, colon and rectum, prostate cases), skin (non-melanoma) and stomach. In addition to surgery, the most widely used traditional types of anti-cancer treatment are radio- and chemotherapy. However, these do not distinguish between normal and malignant cells. Additional treatment methods have evolved over time for early detection and targeted therapy of cancer. However, each method has its limitations and the associated treatment costs are quite high with adverse effects on the quality of life of patients. Use of individual atoms or a cluster of atoms (nanoparticles) can cause a paradigm shift by virtue of providing point of sight sensing and diagnosis of cancer. Nanoparticles (1-100 nm in size) are 1000 times smaller in size than the human cell and endowed with safer relocation capability to attack mechanically and chemically at a precise location which is one avenue that can be used to destroy cancer cells precisely. This review summarises the extant understanding and the work done in this area to pave the way for physicians to accelerate the use of hybrid mode of treatments by leveraging the use of various nanoparticles.
Collapse
Affiliation(s)
- Jaya Verma
- School of Engineering, London South Bank University, London, SE10AA UK
| | - Caaisha Warsame
- School of Engineering, London South Bank University, London, SE10AA UK
| | | | | | - Eiman Aleem
- School of Applied Sciences, Division of Human Sciences, Cancer Biology and Therapy Research Group, London South Bank University, London, SE10AA UK
| | - Saurav Goel
- School of Engineering, London South Bank University, London, SE10AA UK
- Department of Mechanical Engineering, University of Petroleum and Energy Studies, Dehradun, 248007 India
| |
Collapse
|
2
|
White BD, Townley HE. Radio Wave-Activated Chemotherapy-A Novel Nanoparticle Thermoresponsive Copolymer Drug Delivery Platform. MATERIALS (BASEL, SWITZERLAND) 2023; 16:2482. [PMID: 36984362 PMCID: PMC10059094 DOI: 10.3390/ma16062482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Revised: 03/10/2023] [Accepted: 03/15/2023] [Indexed: 06/18/2023]
Abstract
Radio waves are highly penetrating, non-ionizing, and cause minimal damage to surrounding tissues. Radio wave control of drug release has been achieved using a novel thermoresponsive copolymer bound to a superparamagnetic iron oxide nanoparticle (SPION) core. A NIPAM-acrylamide-methacrolein copolymer underwent a coil-to-globular structure phase change upon reaching a critical temperature above the human body temperature but below hyperthermic temperatures. The copolymer was covalently bound to SPIONs which increase in temperature upon exposure to radio waves. This effect could be controlled by varying input energies and frequencies. For controlled drug release, proteins were bound via aldehyde groups on the copolymer and amine groups on the protein. The radio wave-induced heating of the complex thereby released the drug-bearing proteins. The fine-tuning of the radio wave exposure allowed multiple cycles of protein-drug release. The fluorescent tagging of the complex by FITC was also achieved in situ, allowing the tagging of the complex. The localization of the complex could also be achieved in vitro under a permanent magnetic field.
Collapse
Affiliation(s)
- Benjamin D. White
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK
| | - Helen E. Townley
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK
- Department of Women’s and Reproductive Health, John Radcliffe Hospital, University of Oxford, Oxford OX1 3PJ, UK
| |
Collapse
|
3
|
Khabirova S, Aleshin G, Anokhin E, Shchukina A, Zubenko A, Fedorova O, Averin A, Trusov L, Kalmykov S. Novel candidate theranostic radiopharmaceutical based on strontium hexaferrite nanoparticles conjugated with azacrown ligand. Dalton Trans 2023; 52:1731-1741. [PMID: 36655497 DOI: 10.1039/d2dt03548k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
In this article, we report to the best of our knowledge the first modification of NPs with ligands for combined radiopharmaceuticals. Nanoparticles with suitable magnetic properties can be used both for diagnostics as a contrast for MRI and for therapy, including the insufficiently studied magneto-mechanical therapy. Strontium hexaferrite is one of the few hard-magnetic materials for which stable biocompatible colloidal solutions can be obtained. Strontium hexaferrite nanoparticles coated with silicon dioxide (SHF@SiO2) were modified with an amino silane coupling agent (3-aminopropyl)triethoxysilane and azacrown ether derivatives with six heteroatoms in rings were covalently linked to the amine group through the carboxyl group. The hard magnetic nanoparticles were then radiolabeled with 207Bi with a labelling yield of up to 99.8%. In vitro experiments showed that the complex SHF@SiO2-APTES-L2-207Bi is stable enough to be a potential theranostic radiopharmaceutical.
Collapse
Affiliation(s)
- Sofia Khabirova
- Lomonosov Moscow State University, 119991 Leninskie Gory, 1/3, Moscow, Russian Federation.
| | - Gleb Aleshin
- Lomonosov Moscow State University, 119991 Leninskie Gory, 1/3, Moscow, Russian Federation.
| | - Evgeny Anokhin
- Lomonosov Moscow State University, 119991 Leninskie Gory, 1/3, Moscow, Russian Federation.
| | - Anna Shchukina
- A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, 119991 Vavilova, 28, GSP-1, Moscow, Russian Federation
| | - Anastasia Zubenko
- A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, 119991 Vavilova, 28, GSP-1, Moscow, Russian Federation
| | - Olga Fedorova
- A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, 119991 Vavilova, 28, GSP-1, Moscow, Russian Federation
| | - Aleksey Averin
- Frumkin Institute of Physical chemistry and Electrochemistry Russian Academy of Sciences, Leninskiy ave. 31b4, Moscow, Russia
| | - Lev Trusov
- Lomonosov Moscow State University, 119991 Leninskie Gory, 1/3, Moscow, Russian Federation.
| | - Stepan Kalmykov
- Lomonosov Moscow State University, 119991 Leninskie Gory, 1/3, Moscow, Russian Federation.
| |
Collapse
|
4
|
An J, Hong H, Won M, Rha H, Ding Q, Kang N, Kang H, Kim JS. Mechanical stimuli-driven cancer therapeutics. Chem Soc Rev 2023; 52:30-46. [PMID: 36511945 DOI: 10.1039/d2cs00546h] [Citation(s) in RCA: 26] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Mechanical stimulation utilizing deep tissue-penetrating and focusable energy sources, such as ultrasound and magnetic fields, is regarded as an emerging patient-friendly and effective therapeutic strategy to overcome the limitations of conventional cancer therapies based on fundamental external stimuli such as light, heat, electricity, radiation, or microwaves. Recent efforts have suggested that mechanical stimuli-driven cancer therapy (henceforth referred to as "mechanical cancer therapy") could provide a direct therapeutic effect and intelligent control to augment other anti-cancer systems as a synergistic combinational cancer treatment. This review article highlights the latest advances in mechanical cancer therapy to present a novel perspective on the fundamental principles of ultrasound- and magnetic field-mediated mechanical forces, including compression, tension, shear force, and torque, that can be generated in a cellular microenvironment using mechanical stimuli-activated functional materials. Additionally, this article will shed light on mechanical cancer therapy and inspire future research to pursue the development of ultrasound- and magnetic-field-activated materials and their applications in this field.
Collapse
Affiliation(s)
- Jusung An
- Department of Chemistry, Korea University, Seoul 02841, Korea.
| | - Hyunsik Hong
- Department of Materials Science and Engineering, Korea University, Seoul 02841, Korea.
| | - Miae Won
- Department of Chemistry, Korea University, Seoul 02841, Korea.
| | - Hyeonji Rha
- Department of Chemistry, Korea University, Seoul 02841, Korea.
| | - Qihang Ding
- Department of Chemistry, Korea University, Seoul 02841, Korea.
| | - Nayeon Kang
- Department of Materials Science and Engineering, Korea University, Seoul 02841, Korea.
| | - Heemin Kang
- Department of Materials Science and Engineering, Korea University, Seoul 02841, Korea.
| | - Jong Seung Kim
- Department of Chemistry, Korea University, Seoul 02841, Korea.
| |
Collapse
|
5
|
Ponomareva S, Joisten H, François T, Naud C, Morel R, Hou Y, Myers T, Joumard I, Dieny B, Carriere M. Magnetic particles for triggering insulin release in INS-1E cells subjected to a rotating magnetic field. NANOSCALE 2022; 14:13274-13283. [PMID: 36056640 DOI: 10.1039/d2nr02009b] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Diabetes is a major global health threat. Both academics and industry are striving to develop effective treatments for this disease. In this work, we present a new approach to induce insulin release from β-islet pancreatic cells (INS-1E) by mechanical stimulation. Two types of experiments were carried out. First, a local stimulation was performed by dispersing anisotropic magnetic particles within the cell medium, which settled down almost immediately on cell plasma membranes. Application of a low frequency magnetic field (up to 40 Hz) generated by a custom-made magnetic device resulted in oscillations of these particles, which then exerted a mechanical constraint on the cell plasma membranes. The second type of experiment consisted of a global stimulation, where cells were grown on magneto-elastic membranes composed of a biocompatible polymer with embedded magnetic particles. Upon application of a rotating magnetic field, magnetic particles within the membrane were attracted towards the field source, resulting in the membrane's vibrations being transmitted to the cells grown on it. In both experiments, the cell response to these mechanical stimulations caused by application of the variable magnetic field was quantified via the measurement of insulin release in the growth medium. We demonstrated that the mechanical action induced by the motion of magnetic particles or by membrane vibrations was an efficient stimulus for insulin granule secretion from β-cells. This opens a wide range of possible applications including the design of a system which triggers insulin secretion by β-islet pancreatic cells on demand.
Collapse
Affiliation(s)
- Svetlana Ponomareva
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SPINTEC, 38000 Grenoble, France.
| | - Helene Joisten
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SPINTEC, 38000 Grenoble, France.
- Univ. Grenoble Alpes, CEA, Leti, 38000 Grenoble, France
| | - Taina François
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SYMMES, 38000 Grenoble, France.
| | - Cecile Naud
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SPINTEC, 38000 Grenoble, France.
| | - Robert Morel
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SPINTEC, 38000 Grenoble, France.
| | - Yanxia Hou
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SYMMES, 38000 Grenoble, France.
| | - Thomas Myers
- Platform Kinetics, Pegholme, Wharfebank Mills, Otley, LS21 3JP, UK
| | - Isabelle Joumard
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SPINTEC, 38000 Grenoble, France.
| | - Bernard Dieny
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SPINTEC, 38000 Grenoble, France.
| | - Marie Carriere
- Univ. Grenoble Alpes, CEA, CNRS, Grenoble INP, IRIG, SYMMES, 38000 Grenoble, France.
| |
Collapse
|
6
|
Abadi B, Yazdanpanah N, Nokhodchi A, Rezaei N. Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives. Adv Drug Deliv Rev 2021; 179:114035. [PMID: 34740765 DOI: 10.1016/j.addr.2021.114035] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Revised: 10/20/2021] [Accepted: 10/28/2021] [Indexed: 12/15/2022]
Abstract
Glioblastoma multiform (GBM) is considered as the most lethal tumor among CNS malignancies. Although immunotherapy has achieved remarkable advances in cancer treatment, it has not shown satisfactory results in GBM patients. Biomaterial science, along with nanobiotechnology, is able to optimize the efficiency of immunotherapy in these patients. They can be employed to provide the specific activation of immune cells in tumor tissue and combinational therapy as well as preventing systemic adverse effects resulting from hyperactivation of immune responses and off-targeting effect. Advance biomaterials in this field are classified into targeting nanocarriers and localized delivery systems. This review will offer an overview of immunotherapy strategies for glioblastoma and advance delivery systems for immunotherapeutics that may have a high potential in glioblastoma treatment.
Collapse
|